and Philippe CasassusWe report a case of aspergillus pericarditis with tamponade complicating invasive pulmonary aspergillosis in a patient treated for acute lymphocytic leukemia. Prolonged antifungal therapy and aggressive surgical treatment cured the pericarditis, without relapse, despite the fact that the patient underwent autologous bone marrow transplantation. In a review of 28 other cases of aspergillus pericarditis, we found that this condition usually had occurred in severely immunocompromised patients and was always the result of contiguous dissemination of Aspergillus from the lung or myocardium. Tamponade was present in eight of 29 patients. Aspergillus antigen was detected in the pericardial fluid of all three patients whose fluid specimens were tested. Aspergillus pericarditis was diagnosed before death in 10 of 29 patients, all of whom had established premortem diagnoses of invasive aspergillosis at other sites and had received antifungal therapy. Three of the four survivors received combined medical and aggressive surgical therapies. The performance of echocardiography early during the course of invasive pulmonary aspergillosis, together with intensive combined therapies, might lower the high mortality associated with aspergillus pericarditis.Invasive aspergillosis (IA) has become a common fungal pergillus and aspergillosis with the terms pericarditis, pericardium, hemopericardium, myocarditis, and pancarditis. We also infection in patients who have profound neutropenia for prolonged periods. The prevalence of IA is estimated to be as high reviewed the published series and reviews on infectious pericarditis and IA in patients with AIDS, chronic granulomatous as 70% among patients who have been granulocytopenic for 1 month [1]. IA is also being observed increasingly in patients disease (CGD), leukemia, lymphoma, and solid organ and bone marrow transplants and in those receiving corticosteroid therwith solid organ transplants, late-stage AIDS, and diabetes mellitus and in those who have received prolonged corticosteroid apy. References cited in the articles reviewed were also scrutinized for potential additional cases. therapy. The most frequent sites of IA are the lungs and nasal sinuses, but dissemination occurs in 20% -30% of immuno-A case could be evaluated when sufficient demographic information was available for the clear identification of an indicompromised patients [2]. Cardiac involvement is uncommon and most often manifests as endocarditis or myocarditis [2]. vidual patient. We considered aspergillus pericarditis to be present in patients who had (1) evidence of clinical and/or Pericardial aspergillosis is rarely diagnosed before death and has been considered always fatal in neutropenic patients [3]. macroscopic involvement of the pericardium during the course of histologically and mycologically confirmed IA, without any We report a case of pericardial aspergillosis with tamponade in which combined antifungal and surgical therapies were sucreported alternative cause of pericarditis; (2) a ...